Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Fatigue
ADR ID BADD_A01626
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.002      Fatigue
Description A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. [CTCAE] The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. [MeSH]
MedDRA Code 10016256
MeSH ID D005221
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Enervation | Exhaustion | Exhaustion due to excessive exertion | Exhaustion due to exposure | Fatigability | Fatigability generalized | Fatigability lumbar | Fatigability of knees | Fatigue | Fatigue extreme | Fatiguability | Lassitude | Loss physical strength | Prostration | TATT | Tired all the time | Tired and heavy | Tired out | Tiredness | Washed-out | Weariness | Worn out | Fatigue aggravated | Depressive weariness | Fatigueability generalised | Chronic fatigue | Fatiguability generalised
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01585Norethindrone--
BADD_D01586Norethindrone acetate--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01589Nortriptyline hydrochloride--
BADD_D01590Nuvaring--
BADD_D01592Obeticholic acid0.250820%
BADD_D01593Obiltoxaximab--
BADD_D01595Octreotide acetate--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin0.000333%
BADD_D01599Olanzapine--
BADD_D01600Olanzapine pamoate--
BADD_D01601Olaparib0.012055%
BADD_D01602Olmesartan--
BADD_D01603Olmesartan medoxomil--
BADD_D01605Olopatadine--
BADD_D01606Olopatadine hydrochloride--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01609Omacetaxine mepesuccinate0.001556%
BADD_D01610Omalizumab--
BADD_D01612Omega-3-carboxylic acids--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01616Onabotulinumtoxina--
BADD_D01617Ondansetron--
BADD_D01618Ondansetron hydrochloride--
BADD_D01621Optimark--
BADD_D01622Orciprenaline--
The 25th Page    First    Pre   25 26 27 28 29    Next   Last    Total 40 Pages
ADReCS-Target
ADR Term Drug Name Target